We have performed ChIP-Seq using antibodies directed against different histone modfications. After bowtie and MACS14 treatment we find that all peaks fall into repeat regions. Worse, all abs give more or less the same peak pattern. Is this a problem of bowtie alignment parameters or MACS14??
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
What were the modifications ie are the antibodies any good? Did you qPCR control regions (negative and positive) after the IP? How much yield did you get from the IP? How many PCR cycles did you do in the library prep PCR? How many reads did you get, and how many aligned? What parameters did you use for bowtie?
It sounds to me like you don't have any enrichment in your sequenced libraries - hopefully by asking these types of questions you can narrow down where something went wrong.
-
I agree with frozenlyse, and suggest running through some basic QC with something like the HOMER package. For example do you see clonal reads (symptom of PCR gone awry),GC bias (symptom of sequence composition issues), and do the reads map within a predictable distance (symptom of good/bad fragment length prep.) My first guess is that one of those measures will point to something "off."
Comment
-
Originally posted by Simon Anders View PostHave you used an input control? If not, your problem is sort of expected, because you will mainly see mapping artifacts and just open chromatin rather then true binding.
Comment
-
Originally posted by frozenlyse View PostIt's only expected if the IP didn't work - Input controls are quite important but if you're not getting peaks in your IP, no amount of Input controls are going to change that... With the caveat that depending on which antibody/pulldown efficiency deciding what is an enriched peak/area may change.
I overlooked that he said they are all in non-mappable regions, i.e., he has no peaks at all, rather than, having many but all the same. Hence, you are right of course, most likely his IP did not work.
Comment
-
Our bowtie settings were as follows:
-a --best -q -m50 -e50 -solexa1.3-quals
We used a control input as reference and qPCRs performed on ChIP samples were all satisfactory for pos and neg controls. The library was amplified at 18 Cycles. The histone abs being used were all tested and passed that test.
Comment
-
Our bowtie settings were as follows:
-a --best -q -m50 -e50 -solexa1.3-quals
We used a control input as reference and qPCRs performed on ChIP samples were all satisfactory for pos and neg controls. The library was amplified at 18 Cycles. The histone abs being used were all tested and passed that test.
Comment
Latest Articles
Collapse
-
by seqadmin
Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...-
Channel: Articles
12-16-2024, 07:57 AM -
-
by seqadmin
Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.
Long-Read Sequencing
Long-read sequencing has seen remarkable advancements,...-
Channel: Articles
12-02-2024, 01:49 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 12-17-2024, 10:28 AM
|
0 responses
33 views
0 likes
|
Last Post
by seqadmin
12-17-2024, 10:28 AM
|
||
Started by seqadmin, 12-13-2024, 08:24 AM
|
0 responses
49 views
0 likes
|
Last Post
by seqadmin
12-13-2024, 08:24 AM
|
||
Started by seqadmin, 12-12-2024, 07:41 AM
|
0 responses
34 views
0 likes
|
Last Post
by seqadmin
12-12-2024, 07:41 AM
|
||
Started by seqadmin, 12-11-2024, 07:45 AM
|
0 responses
46 views
0 likes
|
Last Post
by seqadmin
12-11-2024, 07:45 AM
|
Comment